Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy.

BACKGROUND: Adoptive transfer of in vitro expanded tumor-infiltrating lymphocytes (TILs) has been effective in regressing several types of malignant tumors. This study assessed the yield and factors influencing the successful expansion of tumor-infiltrating lymphocytes (TILs) from head and neck squamous cell carcinoma (HNSCC), along with their immune phenotypes. METHODS: TILs were expanded from 47 surgically resected HNSCC specimens and their metastasized lymph nodes. The cancer tissues were cut into small pieces (1-2 mm) and underwent initial expansion for 2 weeks. Tumor location, smoking history, stromal TIL percentage, human papillomavirus infection, and programmed death-ligand 1 score were examined for their impact on successful expansion of TILs. Expanded TILs were evaluated by flow cytometry using fluorescence-activated cell sorting. A second round of TIL expansion following the rapid expansion protocol was performed on a subset of samples with successful TIL expansion. RESULTS: TILs were successfully expanded from 36.2% samples. Failure was due to contamination (27.6%) or insufficient expansion (36.2%). Only the stromal TIL percentage was significantly associated with successful TIL expansion (p = 0.032). The stromal TIL percentage also displayed a correlation with the expanded TILs per fragment (r = 0.341, p = 0.048). On flow cytometry analysis using 13 samples with successful TIL expansion, CD4 + T cell dominancy was seen in 69.2% of cases. Effector memory T cells were the major phenotype of expanded CD4 + and CD8 + T cells in all cases. CONCLUSION: We could expand TILs from approximately one-third of HNSCC samples. TIL expansion could be applicable in HNSCC samples with diverse clinicopathological characteristics.

Tumor-infiltrating lymphocyte therapy: Clinical aspects and future developments in this breakthrough cancer treatment.

Tumor-infiltrating lymphocyte (TIL) therapy is a promising approach for treating refractory or advanced solid cancers by using autologous TILs harvested from cancer tissues. Despite the heterogeneity of cancer, TIL therapy can potentially produce a positive therapeutic response, including complete remission. After decades of research on lymphocyte functions, culture/expansion methods, therapeutic protocols, and multiple clinical trials, TIL therapy has finally reached a stage where it can be formally approved for clinical use. TIL therapy is expected to hold a unique position among anti-cancer therapeutic options as a standard intervention. To successfully introduce TIL therapy into clinical settings, there is a need to expand therapeutic indications and set up the best protocols for cancer tissue sampling and manufacturing, and related clinical trials. Moreover, studies on next-generation TIL therapy have already begun, and post-approval real-world data will promote and support further research.

Trace element bioaccumulation in edible red seaweeds (Rhodophyta): A risk assessment for consumers.

As a precursor to risk assessment and risk management through consuming contaminated seafood, food safety needs to be quantified and assured. Seaweed is an increasing dietary component, especially in developing countries, but there are few studies assessing uptake rates of contaminants from this route. As such, the present study determined likely human uptake due to the trace elemental (Fe, Mn, Ni, Cu, Zn, Se, Hg, and As) concentrations in the edible red seaweeds (Rhodophyta) Gelidium pusillum and Hypnea musciformis, growing in the industrialised Cox's Bazar coastal area of Bangladesh. Metal and metalloid concentrations in G. pusillum were in the order (mg/kg): Fe (797 ± 67) > Mn (69 ± 4) > Ni (12 ± 5) > Zn (9 ± 4) > Cu (9 ± 4) >Se (0.1 ± 0.1) > Hg (0.1 ± 0.01), and in H. musciformis: Fe (668 ± 58) > Mn (28 ± 5) > Ni (14 ± 2) > Zn (11 ± 5) > Cu (6 ± 4) >Se (0.2 ± 0.03) > Hg (0.04 ± 0.01). Despite the industrial activities in the area, and based on 10 g. day-1 seaweed consumption, it is concluded that these concentrations pose no risk to human health as part of a normal diet according to the targeted hazard quotient and hazard index (THQ and HI) (values < 1). In addition, and as a novel aspect for seaweeds, Selenium Health Benefit Values (Se-HBV) were determined and found to have positive values. Seaweed can be used as an absorber of inorganic metals for removing contamination in coastal waters. The results are a precursor to further research regarding the efficiency and rate at which seaweeds can sequester metal contamination in water. In addition, management techniques need to be developed thereby to control the contaminant inputs.